1 | inhibitors | 18,790 |
2 | inhibitors/arbs | 72 |
3 | inactivators | 12 |
4 | manipulators | 10 |
5 | beta/delta | 9 |
6 | 2b1 | 7 |
7 | i555 | 7 |
8 | deactivator | 6 |
9 | epoxygenases | 6 |
10 | h-hss | 5 |
11 | leprk2 | 5 |
12 | zedong | 5 |
13 | c-θ | 4 |
14 | inhibitor-a | 4 |
15 | inhibitors/ | 4 |
16 | inhibitors/arb | 4 |
17 | kinase-3beta | 4 |
18 | producibility | 4 |
19 | 3beta | 3 |
20 | co-transporters | 3 |
21 | hsp150delta-beta-lactamase | 3 |
22 | inhibitor-c-a | 3 |
23 | inhibitor-c-i | 3 |
24 | inibitors | 3 |
25 | ko/apoer61 | 3 |
26 | -1486t/c | 2 |
27 | 101-d | 2 |
28 | 2b7 | 2 |
29 | 3-ketosteroid-δ | 2 |
30 | activation/phosphorylation | 2 |
31 | adventitium | 2 |
32 | alanine-glyoxylate | 2 |
33 | antisense-oligonucleotides | 2 |
34 | blockade-induced | 2 |
35 | c-4502t | 2 |
36 | cepsilon | 2 |
37 | colfosceril | 2 |
38 | cwlj | 2 |
39 | cδ | 2 |
40 | drpll | 2 |
41 | duox1 | 2 |
42 | expression[ | 2 |
43 | fab1/pikfyve | 2 |
44 | g-971a | 2 |
45 | homology-2 | 2 |
46 | inhibiter | 2 |
47 | inhibitiors | 2 |
48 | inhibitor-acei | 2 |
49 | inhibitor-drm | 2 |
50 | inhibitor-nitrates | 2 |
51 | inhibitor/amoxicillin | 2 |
52 | inhibitors- | 2 |
53 | inhibitors-arbs | 2 |
54 | inhibitors/sartans | 2 |
55 | kewense | 2 |
56 | mpr1/2 | 2 |
57 | non-inhibitors | 2 |
58 | operatives | 2 |
59 | pan-inhibitors | 2 |
60 | pea29 | 2 |
61 | reactivase | 2 |
62 | rs4315495 | 2 |
63 | selectives | 2 |
64 | ubc13 | 2 |
65 | α-l-iduronidase | 2 |
66 | 'insertion | 1 |
67 | *2c | 1 |
68 | -c677t | 1 |
69 | 1,2-acylcoa | 1 |
70 | 1/slc36a1 | 1 |
71 | 106,874 | 1 |
72 | 110,500 | 1 |
73 | 1276a/g | 1 |
74 | 1b10 | 1 |
75 | 1b7 | 1 |
76 | 2-chloro-4-nitropyridine | 1 |
77 | 2-heptyl-3-hydroxy-4-quinolone | 1 |
78 | 2/angiotensin | 1 |
79 | 2/slc38a2 | 1 |
80 | 27,168 | 1 |
81 | 2b10 | 1 |
82 | 3,6-dichloro-4-methylpyridazine | 1 |
83 | 3/apxr4/catr2 | 1 |
84 | 3α-hsd2/17β-hsd5 | 1 |
85 | 421c/a | 1 |
86 | 5-enol-pyruvyl-shikimate-3-phosphate | 1 |
87 | 5-phosphotransferase | 1 |
88 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase | 1 |
89 | 825,900 | 1 |
90 | a1-like | 1 |
91 | a1267g | 1 |
92 | activity/mrna | 1 |
93 | agonist/pams | 1 |
94 | aldolase/phosphatase | 1 |
95 | alpha/ml | 1 |
96 | antagonists-3-bromopyruvate | 1 |
97 | autoimmunologists | 1 |
98 | bcrabl | 1 |
99 | b¹σ | 1 |
100 | c-activating | 1 |
101 | c-ζ | 1 |
102 | cbra | 1 |
103 | ch3ch2oc | 1 |
104 | closo-ruthenacarboranes | 1 |
105 | co-activator-1 | 1 |
106 | conductances/synapse | 1 |
107 | cryptantigens | 1 |
108 | di+ii | 1 |
109 | dp110 | 1 |
110 | ecto-α-subunit | 1 |
111 | enhancement-agent | 1 |
112 | gerogene | 1 |
113 | glyoxalase-1 | 1 |
114 | gmfad2-3 | 1 |
115 | gsk3p3 | 1 |
116 | homolog3 | 1 |
117 | homology/collagen | 1 |
118 | hprk/p | 1 |
119 | hpych4iv | 1 |
120 | hua1 | 1 |
121 | hxt5 | 1 |
122 | hyperconcentration | 1 |
123 | i-leucine | 1 |
124 | iduronate-2-sulphatase | 1 |
125 | iduronate2-sulfatase | 1 |
126 | iiab | 1 |
127 | ile405val | 1 |
128 | in-hibitors | 1 |
129 | inhi-bitors | 1 |
130 | inhibitor-impi | 1 |
131 | inhibitor-perindopril | 1 |
132 | inhibitor-sensitizing | 1 |
133 | inhibitor-withdrawn | 1 |
134 | inhibitor-ш | 1 |
135 | inhibitor/arbs | 1 |
136 | inhibitor/ccb | 1 |
137 | inhibitor/mineral | 1 |
138 | inhibitor/mmf/corticosteroids | 1 |
139 | inhibitor/niacin | 1 |
140 | inhibitor/nucleoside | 1 |
141 | inhibitor/placebo | 1 |
142 | inhibitor/rbc-c-a | 1 |
143 | inhibitor/rbc-c-i | 1 |
144 | inhibitor/venlafaxine | 1 |
145 | inhibitors-atorvastatin | 1 |
146 | inhibitors-duloxetine | 1 |
147 | inhibitors-exemestane | 1 |
148 | inhibitors-fluvastatin | 1 |
149 | inhibitors-lovastatin | 1 |
150 | inhibitors.to | 1 |
151 | inhibitors/arbs/β-blockers | 1 |
152 | inhibitors=0.79 | 1 |
153 | integrinα | 1 |
154 | isoenzyme-1 | 1 |
155 | kinase-3-β | 1 |
156 | kinase-3/dynamin-dependent | 1 |
157 | kinase3-β | 1 |
158 | kinse-3 | 1 |
159 | l-phosphoserine | 1 |
160 | ll55 | 1 |
161 | loss=2/11 | 1 |
162 | lyticase | 1 |
163 | microcystinase | 1 |
164 | mirk/dyrk1b | 1 |
165 | monoxygenases | 1 |
166 | mpk-1 | 1 |
167 | mrhgdissshdtvgi | 1 |
168 | mu1-1 | 1 |
169 | mutation=3/11 | 1 |
170 | nant | 1 |
171 | napab | 1 |
172 | nexobrid™ | 1 |
173 | nmar_1110 | 1 |
174 | null-mutant | 1 |
175 | overexpression/accumulation | 1 |
176 | p.g87v | 1 |
177 | p1-1 | 1 |
178 | paroxonase | 1 |
179 | passivations | 1 |
180 | peroxydase | 1 |
181 | phosphodiesterasel | 1 |
182 | pias2 | 1 |
183 | proto-oncogen | 1 |
184 | psd1 | 1 |
185 | pt121 | 1 |
186 | r4496 | 1 |
187 | rs2305809 | 1 |
188 | rs4343 | 1 |
189 | ser465/467 | 1 |
190 | slt2/mpk1 | 1 |
191 | spafeg | 1 |
192 | ssa-250a | 1 |
193 | sse2 | 1 |
194 | subunit-2 | 1 |
195 | thermal-adaptation | 1 |
196 | tricarbonyldichlororuthenium | 1 |
197 | wa50120a | 1 |
198 | wq9-2 | 1 |
199 | xar-l1-xyn | 1 |
200 | xinhibitors | 1 |
201 | ze-dong | 1 |
202 | znts | 1 |
203 | α/βii | 1 |
204 | ω-1 | 1 |
1 | 'insertion | 1 |
2 | *2c | 1 |
3 | -1486t/c | 2 |
4 | -c677t | 1 |
5 | 1,2-acylcoa | 1 |
6 | 1/slc36a1 | 1 |
7 | 101-d | 2 |
8 | 106,874 | 1 |
9 | 110,500 | 1 |
10 | 1276a/g | 1 |
11 | 1b10 | 1 |
12 | 1b7 | 1 |
13 | 2-chloro-4-nitropyridine | 1 |
14 | 2-heptyl-3-hydroxy-4-quinolone | 1 |
15 | 2/angiotensin | 1 |
16 | 2/slc38a2 | 1 |
17 | 27,168 | 1 |
18 | 2b1 | 7 |
19 | 2b10 | 1 |
20 | 2b7 | 2 |
21 | 3,6-dichloro-4-methylpyridazine | 1 |
22 | 3-ketosteroid-δ | 2 |
23 | 3/apxr4/catr2 | 1 |
24 | 3beta | 3 |
25 | 3α-hsd2/17β-hsd5 | 1 |
26 | 421c/a | 1 |
27 | 5-enol-pyruvyl-shikimate-3-phosphate | 1 |
28 | 5-phosphotransferase | 1 |
29 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase | 1 |
30 | 825,900 | 1 |
31 | a1-like | 1 |
32 | a1267g | 1 |
33 | activation/phosphorylation | 2 |
34 | activity/mrna | 1 |
35 | adventitium | 2 |
36 | agonist/pams | 1 |
37 | alanine-glyoxylate | 2 |
38 | aldolase/phosphatase | 1 |
39 | alpha/ml | 1 |
40 | antagonists-3-bromopyruvate | 1 |
41 | antisense-oligonucleotides | 2 |
42 | autoimmunologists | 1 |
43 | bcrabl | 1 |
44 | beta/delta | 9 |
45 | blockade-induced | 2 |
46 | b¹σ | 1 |
47 | c-4502t | 2 |
48 | c-activating | 1 |
49 | c-ζ | 1 |
50 | c-θ | 4 |
51 | cbra | 1 |
52 | cepsilon | 2 |
53 | ch3ch2oc | 1 |
54 | closo-ruthenacarboranes | 1 |
55 | co-activator-1 | 1 |
56 | co-transporters | 3 |
57 | colfosceril | 2 |
58 | conductances/synapse | 1 |
59 | cryptantigens | 1 |
60 | cwlj | 2 |
61 | cδ | 2 |
62 | deactivator | 6 |
63 | di+ii | 1 |
64 | dp110 | 1 |
65 | drpll | 2 |
66 | duox1 | 2 |
67 | ecto-α-subunit | 1 |
68 | enhancement-agent | 1 |
69 | epoxygenases | 6 |
70 | expression[ | 2 |
71 | fab1/pikfyve | 2 |
72 | g-971a | 2 |
73 | gerogene | 1 |
74 | glyoxalase-1 | 1 |
75 | gmfad2-3 | 1 |
76 | gsk3p3 | 1 |
77 | h-hss | 5 |
78 | homolog3 | 1 |
79 | homology-2 | 2 |
80 | homology/collagen | 1 |
81 | hprk/p | 1 |
82 | hpych4iv | 1 |
83 | hsp150delta-beta-lactamase | 3 |
84 | hua1 | 1 |
85 | hxt5 | 1 |
86 | hyperconcentration | 1 |
87 | i-leucine | 1 |
88 | i555 | 7 |
89 | iduronate-2-sulphatase | 1 |
90 | iduronate2-sulfatase | 1 |
91 | iiab | 1 |
92 | ile405val | 1 |
93 | in-hibitors | 1 |
94 | inactivators | 12 |
95 | inhi-bitors | 1 |
96 | inhibiter | 2 |
97 | inhibitiors | 2 |
98 | inhibitor-a | 4 |
99 | inhibitor-acei | 2 |
100 | inhibitor-c-a | 3 |
101 | inhibitor-c-i | 3 |
102 | inhibitor-drm | 2 |
103 | inhibitor-impi | 1 |
104 | inhibitor-nitrates | 2 |
105 | inhibitor-perindopril | 1 |
106 | inhibitor-sensitizing | 1 |
107 | inhibitor-withdrawn | 1 |
108 | inhibitor-ш | 1 |
109 | inhibitor/amoxicillin | 2 |
110 | inhibitor/arbs | 1 |
111 | inhibitor/ccb | 1 |
112 | inhibitor/mineral | 1 |
113 | inhibitor/mmf/corticosteroids | 1 |
114 | inhibitor/niacin | 1 |
115 | inhibitor/nucleoside | 1 |
116 | inhibitor/placebo | 1 |
117 | inhibitor/rbc-c-a | 1 |
118 | inhibitor/rbc-c-i | 1 |
119 | inhibitor/venlafaxine | 1 |
120 | inhibitors | 18,790 |
121 | inhibitors- | 2 |
122 | inhibitors-arbs | 2 |
123 | inhibitors-atorvastatin | 1 |
124 | inhibitors-duloxetine | 1 |
125 | inhibitors-exemestane | 1 |
126 | inhibitors-fluvastatin | 1 |
127 | inhibitors-lovastatin | 1 |
128 | inhibitors.to | 1 |
129 | inhibitors/ | 4 |
130 | inhibitors/arb | 4 |
131 | inhibitors/arbs | 72 |
132 | inhibitors/arbs/β-blockers | 1 |
133 | inhibitors/sartans | 2 |
134 | inhibitors=0.79 | 1 |
135 | inibitors | 3 |
136 | integrinα | 1 |
137 | isoenzyme-1 | 1 |
138 | kewense | 2 |
139 | kinase-3-β | 1 |
140 | kinase-3/dynamin-dependent | 1 |
141 | kinase-3beta | 4 |
142 | kinase3-β | 1 |
143 | kinse-3 | 1 |
144 | ko/apoer61 | 3 |
145 | l-phosphoserine | 1 |
146 | leprk2 | 5 |
147 | ll55 | 1 |
148 | loss=2/11 | 1 |
149 | lyticase | 1 |
150 | manipulators | 10 |
151 | microcystinase | 1 |
152 | mirk/dyrk1b | 1 |
153 | monoxygenases | 1 |
154 | mpk-1 | 1 |
155 | mpr1/2 | 2 |
156 | mrhgdissshdtvgi | 1 |
157 | mu1-1 | 1 |
158 | mutation=3/11 | 1 |
159 | nant | 1 |
160 | napab | 1 |
161 | nexobrid™ | 1 |
162 | nmar_1110 | 1 |
163 | non-inhibitors | 2 |
164 | null-mutant | 1 |
165 | operatives | 2 |
166 | overexpression/accumulation | 1 |
167 | p.g87v | 1 |
168 | p1-1 | 1 |
169 | pan-inhibitors | 2 |
170 | paroxonase | 1 |
171 | passivations | 1 |
172 | pea29 | 2 |
173 | peroxydase | 1 |
174 | phosphodiesterasel | 1 |
175 | pias2 | 1 |
176 | producibility | 4 |
177 | proto-oncogen | 1 |
178 | psd1 | 1 |
179 | pt121 | 1 |
180 | r4496 | 1 |
181 | reactivase | 2 |
182 | rs2305809 | 1 |
183 | rs4315495 | 2 |
184 | rs4343 | 1 |
185 | selectives | 2 |
186 | ser465/467 | 1 |
187 | slt2/mpk1 | 1 |
188 | spafeg | 1 |
189 | ssa-250a | 1 |
190 | sse2 | 1 |
191 | subunit-2 | 1 |
192 | thermal-adaptation | 1 |
193 | tricarbonyldichlororuthenium | 1 |
194 | ubc13 | 2 |
195 | wa50120a | 1 |
196 | wq9-2 | 1 |
197 | xar-l1-xyn | 1 |
198 | xinhibitors | 1 |
199 | ze-dong | 1 |
200 | zedong | 5 |
201 | znts | 1 |
202 | α-l-iduronidase | 2 |
203 | α/βii | 1 |
204 | ω-1 | 1 |
1 | inhibitors- | 2 |
2 | inhibitors/ | 4 |
3 | 110,500 | 1 |
4 | 825,900 | 1 |
5 | nmar_1110 | 1 |
6 | dp110 | 1 |
7 | 1b10 | 1 |
8 | 2b10 | 1 |
9 | p1-1 | 1 |
10 | mu1-1 | 1 |
11 | isoenzyme-1 | 1 |
12 | glyoxalase-1 | 1 |
13 | mpk-1 | 1 |
14 | co-activator-1 | 1 |
15 | ω-1 | 1 |
16 | loss=2/11 | 1 |
17 | mutation=3/11 | 1 |
18 | pt121 | 1 |
19 | ko/apoer61 | 3 |
20 | 1/slc36a1 | 1 |
21 | hua1 | 1 |
22 | 2b1 | 7 |
23 | psd1 | 1 |
24 | slt2/mpk1 | 1 |
25 | duox1 | 2 |
26 | wq9-2 | 1 |
27 | subunit-2 | 1 |
28 | homology-2 | 2 |
29 | mpr1/2 | 2 |
30 | 2/slc38a2 | 1 |
31 | sse2 | 1 |
32 | leprk2 | 5 |
33 | 3/apxr4/catr2 | 1 |
34 | pias2 | 1 |
35 | gmfad2-3 | 1 |
36 | kinse-3 | 1 |
37 | ubc13 | 2 |
38 | rs4343 | 1 |
39 | homolog3 | 1 |
40 | gsk3p3 | 1 |
41 | 106,874 | 1 |
42 | i555 | 7 |
43 | ll55 | 1 |
44 | rs4315495 | 2 |
45 | 3α-hsd2/17β-hsd5 | 1 |
46 | hxt5 | 1 |
47 | r4496 | 1 |
48 | ser465/467 | 1 |
49 | 1b7 | 1 |
50 | 2b7 | 2 |
51 | 27,168 | 1 |
52 | rs2305809 | 1 |
53 | pea29 | 2 |
54 | inhibitors=0.79 | 1 |
55 | inhibitor/rbc-c-a | 1 |
56 | inhibitor-c-a | 3 |
57 | inhibitor-a | 4 |
58 | 421c/a | 1 |
59 | wa50120a | 1 |
60 | ssa-250a | 1 |
61 | g-971a | 2 |
62 | activity/mrna | 1 |
63 | 1,2-acylcoa | 1 |
64 | cbra | 1 |
65 | 3beta | 3 |
66 | kinase-3beta | 4 |
67 | beta/delta | 9 |
68 | mirk/dyrk1b | 1 |
69 | iiab | 1 |
70 | napab | 1 |
71 | inhibitor/ccb | 1 |
72 | inhibitors/arb | 4 |
73 | -1486t/c | 2 |
74 | *2c | 1 |
75 | ch3ch2oc | 1 |
76 | 101-d | 2 |
77 | blockade-induced | 2 |
78 | inhibitor/nucleoside | 1 |
79 | a1-like | 1 |
80 | inhibitors-exemestane | 1 |
81 | gerogene | 1 |
82 | i-leucine | 1 |
83 | 2-chloro-4-nitropyridine | 1 |
84 | l-phosphoserine | 1 |
85 | inhibitors-duloxetine | 1 |
86 | inhibitor/venlafaxine | 1 |
87 | 3,6-dichloro-4-methylpyridazine | 1 |
88 | 2-heptyl-3-hydroxy-4-quinolone | 1 |
89 | lyticase | 1 |
90 | α-l-iduronidase | 2 |
91 | peroxydase | 1 |
92 | hsp150delta-beta-lactamase | 3 |
93 | microcystinase | 1 |
94 | paroxonase | 1 |
95 | 5-phosphotransferase | 1 |
96 | iduronate2-sulfatase | 1 |
97 | iduronate-2-sulphatase | 1 |
98 | aldolase/phosphatase | 1 |
99 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase | 1 |
100 | reactivase | 2 |
101 | kewense | 2 |
102 | conductances/synapse | 1 |
103 | 5-enol-pyruvyl-shikimate-3-phosphate | 1 |
104 | alanine-glyoxylate | 2 |
105 | antagonists-3-bromopyruvate | 1 |
106 | fab1/pikfyve | 2 |
107 | 1276a/g | 1 |
108 | a1267g | 1 |
109 | spafeg | 1 |
110 | c-activating | 1 |
111 | inhibitor-sensitizing | 1 |
112 | ze-dong | 1 |
113 | zedong | 5 |
114 | inhibitor/rbc-c-i | 1 |
115 | inhibitor-c-i | 3 |
116 | inhibitor-acei | 2 |
117 | mrhgdissshdtvgi | 1 |
118 | di+ii | 1 |
119 | α/βii | 1 |
120 | inhibitor-impi | 1 |
121 | cwlj | 2 |
122 | inhibitor/mineral | 1 |
123 | ile405val | 1 |
124 | bcrabl | 1 |
125 | phosphodiesterasel | 1 |
126 | colfosceril | 2 |
127 | inhibitor-perindopril | 1 |
128 | drpll | 2 |
129 | alpha/ml | 1 |
130 | inhibitor-drm | 2 |
131 | tricarbonyldichlororuthenium | 1 |
132 | adventitium | 2 |
133 | homology/collagen | 1 |
134 | proto-oncogen | 1 |
135 | inhibitor/niacin | 1 |
136 | inhibitor/amoxicillin | 2 |
137 | 2/angiotensin | 1 |
138 | inhibitors-lovastatin | 1 |
139 | inhibitors-atorvastatin | 1 |
140 | inhibitors-fluvastatin | 1 |
141 | overexpression/accumulation | 1 |
142 | activation/phosphorylation | 2 |
143 | hyperconcentration | 1 |
144 | thermal-adaptation | 1 |
145 | 'insertion | 1 |
146 | cepsilon | 2 |
147 | inhibitor-withdrawn | 1 |
148 | xar-l1-xyn | 1 |
149 | inhibitor/placebo | 1 |
150 | inhibitors.to | 1 |
151 | hprk/p | 1 |
152 | inhibiter | 2 |
153 | deactivator | 6 |
154 | inhibitors-arbs | 2 |
155 | inhibitor/arbs | 1 |
156 | inhibitors/arbs | 72 |
157 | inhibitor/mmf/corticosteroids | 1 |
158 | antisense-oligonucleotides | 2 |
159 | closo-ruthenacarboranes | 1 |
160 | monoxygenases | 1 |
161 | epoxygenases | 6 |
162 | inhibitor-nitrates | 2 |
163 | operatives | 2 |
164 | selectives | 2 |
165 | agonist/pams | 1 |
166 | inhibitors/sartans | 2 |
167 | cryptantigens | 1 |
168 | passivations | 1 |
169 | inhibitors/arbs/β-blockers | 1 |
170 | co-transporters | 3 |
171 | inhibitiors | 2 |
172 | manipulators | 10 |
173 | inactivators | 12 |
174 | inhi-bitors | 1 |
175 | in-hibitors | 1 |
176 | inhibitors | 18,790 |
177 | pan-inhibitors | 2 |
178 | non-inhibitors | 2 |
179 | xinhibitors | 1 |
180 | inibitors | 3 |
181 | h-hss | 5 |
182 | znts | 1 |
183 | autoimmunologists | 1 |
184 | c-4502t | 2 |
185 | -c677t | 1 |
186 | ecto-α-subunit | 1 |
187 | nant | 1 |
188 | null-mutant | 1 |
189 | kinase-3/dynamin-dependent | 1 |
190 | enhancement-agent | 1 |
191 | p.g87v | 1 |
192 | hpych4iv | 1 |
193 | producibility | 4 |
194 | b¹σ | 1 |
195 | inhibitor-ш | 1 |
196 | nexobrid™ | 1 |
197 | integrinα | 1 |
198 | kinase-3-β | 1 |
199 | kinase3-β | 1 |
200 | 3-ketosteroid-δ | 2 |
201 | cδ | 2 |
202 | c-ζ | 1 |
203 | c-θ | 4 |
204 | expression[ | 2 |